| Literature DB >> 32727165 |
Sarah Amalina Adli1, Fathilah Ali1, Azlin Suhaida Azmi1, Hazleen Anuar2, Nur Aimi Mohd Nasir2, Rosnani Hasham3, Mohamad Khairul Hafiz Idris3.
Abstract
The usage of non-degradable polymer as the main matrix for a cosmetic patch raises concern, as it can cause environmental pollution when discarded in landfill. Thus, biodegradable polylactic acid (PLA) was chosen in this study, as PLA has non-toxic properties and similar mechanical properties to conventional plastic materials. An active ingredient in a cosmetic patch serves the purpose of providing beneficial ingredients to the skin; therefore, phycocyanin, an extract from spirulina, was chosen, as it possesses antioxidant and anti-inflammatory properties. Alginate was also incorporated with the phycocyanin for fabrication onto the PLA matrix. A preliminary study was first carried out to identify the antioxidant properties and cytotoxic effect of the phycocyanin on skin cells. It was observed that phycocyanin had no cytotoxic effect on the skin and showed good antioxidant activity. PLA/phycocyanin-alginate composite was fabricated using a solvent casting method, and optimization of preparation conditions (phycocyanin/alginate ratio, stirring time, and temperature) were carried out using the one-factor-at-a-time (OFAT) method with responses of elongation at break and releasing properties. Attenuated total reflectance (ATR)-FTIR analysis was also conducted to further analyze the functional group of the composites. Surface morphologies were observed for samples before and after the releasing test. From the analyses conducted, PLA/phycocyanin-alginate composite prepared at a phycocyanin/alginate ratio of 40/60 for 20 h at 20 °C gave the best properties in terms of flexibility of film and releasing properties of phycocyanin.Entities:
Keywords: PLA; alginate; cosmetic; patches; phycocyanin; spirulina extract
Year: 2020 PMID: 32727165 PMCID: PMC7463478 DOI: 10.3390/polym12081669
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Schematic diagram of two layers of the composite.
Figure 2Cytotoxicity effects of phycocyanin on the HSF1184 cell.
Antioxidant activity of the phycocyanin.
| Phycocyanin Concentration (µg/mL) | DPPH Scavenging Activity (% Inhibition) |
|---|---|
| 19.53 | 39.26 |
| 39.06 | 46.16 |
| 78.13 | 48.98 |
| 156.25 | 52.17 |
| 312.50 | 59.46 |
| 625.00 | 67.90 |
Figure 3Elongation at break of patches with various phycocyanin/alginate ratios.
Figure 4Releasing test of patches with various phycocyanin/alginate ratios.
Percentage of phycocyanin released.
| Phycocyanin/Alginate Ratio | Percentage Release ( |
|---|---|
| 50/50 | 30.52 |
| 40/60 | 30.18 |
| 30/70 | 34.93 |
| 20/80 | 36.45 |
| 10/90 | 45.56 |
Figure 5Elongation at break of patches prepared at different stirring times.
Figure 6Releasing test of patches prepared at different stirring times (phycocyanin/alginate ratio at 40/60).
Figure 7Elongation at break of patches prepared at different mixing temperatures.
Figure 8Releasing test of patches prepared at different mixing temperatures.
Figure 9SEM micrographs of polylactic acid (PLA)/phycocyanin–alginate composite (a) before and (b) after the releasing test.
Figure 10Attenuated total reflectance (ATR)–FTIR spectra for PLA/phycocyanin–alginate composites (20 °C) before and after the releasing test.